virus
bacteria
may
colon
nasopharynx
np
oropharynx
op
without
caus
infect
advanc
molecular
test
microbi
antigen
detect
enhanc
sensit
may
allow
detect
colon
postinfecti
shed
respiratori
pathogen
without
clinic
signific
respiratori
virus
herp
virus
includ
epsteinbarr
ebv
herp
simplex
viru
hsv
cytomegaloviru
cmv
associ
chronic
intermitt
asymptomat
nucleic
acid
shed
streptococc
carrier
low
risk
spread
gabh
close
contact
requir
antibiot
treatment
minim
risk
develop
rheumat
fever
streptococc
carriag
may
persist
mani
month
frequent
pose
diagnost
challeng
symptomat
viral
uri
develop
carrier
low
predict
valu
throat
swab
relat
preval
carrier
rate
neither
blood
agar
plate
cultur
rapid
antigen
test
accur
differenti
individu
true
gabh
pharyng
gabh
carrier
studi
shown
children
gabh
isol
upper
respiratori
tract
present
symptom
tonsil
pharyng
demonstr
system
immun
respons
group
strep
cultur
op
associ
antibodi
respons
characterist
true
infect
crp
elev
time
convers
patient
neg
initi
crp
test
seldom
show
rise
antibodi
titer
crp
mgml
high
carrier
rate
gabh
falseposit
diagnos
may
contribut
appar
failur
rate
approxim
penicillin
therapi
valkenburg
et
al
shown
antistreptococc
antibodi
titer
accur
throat
cultur
predict
therapeut
outcom
differenti
infect
colon
requir
demonstr
antibodi
respons
howev
prove
immun
respons
timeconsum
may
lead
falseneg
result
follow
appropri
antibiot
therapi
studi
ivaska
et
al
show
patient
present
pharyng
signific
differ
mean
initi
serum
antistreptolysin
aso
level
gabh
nongabh
patient
patient
show
aso
increas
pair
serum
sampl
patient
antibodi
respons
gabh
posit
gcbh
posit
neg
streptococci
throat
cultur
convers
blood
mxa
level
found
elev
patient
viral
pharyng
remain
low
patient
gabh
without
viru
detect
mxa
express
peripher
blood
highli
specif
marker
viral
infect
mxa
intracellular
blood
protein
mediat
cellular
resist
wide
rang
virus
elev
presenc
acut
activ
viral
infect
includ
influenza
b
respiratori
syncyti
viru
parainfluenzavirus
epsteinbarrr
herp
simplex
cytomegaloviru
adenoviru
coronaviru
rhinoviru
metapneumoviru
infect
howev
specif
particular
type
viru
interferon
ifn
natur
occur
protein
import
part
host
innat
defens
mechan
releas
respons
viral
infect
mxa
gene
express
blood
mononuclear
cell
local
tissu
express
upregul
exclus
type
ifn
mxa
gene
respond
cytokin
neither
type
ifn
mxa
elev
healthi
patient
present
bacteri
infect
case
acut
viral
infect
type
ifn
mxa
releas
peripher
blood
detect
interferon
serum
difficult
unreli
mainli
due
short
halflif
contrast
mxa
long
halflif
day
low
baselin
level
less
ngml
fast
induct
time
hour
infect
low
basal
level
mxa
protein
tissu
exclus
express
type
ifn
rel
long
halflif
make
excel
biomark
system
product
viral
infect
recent
studi
show
viral
biomark
tnfrelat
apoptosisinduc
ligand
trail
less
effect
mxa
differenti
viral
infect
trail
show
area
curv
auc
specif
viral
infect
studi
support
superior
mxa
biomark
identifi
viral
infect
especi
uri
crp
nonspecif
acutephas
protein
increas
inflammatori
process
sever
infect
normal
crp
serum
concentr
less
mgl
rise
mgl
presenc
sever
inflamm
infect
high
crp
level
gener
indic
bacteri
rather
viral
infect
also
use
assess
diseas
sever
systemat
review
acut
rhinosinus
show
crp
less
mgl
provid
evid
bacteri
sinus
crp
greater
mgl
show
evid
support
bacteri
sinus
calvino
et
al
show
crp
elev
mgl
nearli
case
gabh
ensur
clinic
signific
infect
would
less
like
miss
could
differenti
viral
bacteri
infect
similarli
putto
et
al
found
examin
children
posit
bacteri
cultur
show
crp
elev
mgl
consist
clinic
signific
bacteri
infect
typic
bacteri
infect
stimulateselev
crp
impact
mxa
level
crp
elev
within
hour
infect
doubl
everi
hour
peak
approxim
hour
although
less
common
bacteri
infect
viral
pathogen
adenoviru
parainfluenzaviru
influenza
respiratori
syncyti
viru
epsteinbarr
viru
herp
simplex
viru
varicella
zoster
viru
rais
crp
level
significantli
mgl
therefor
test
system
util
crp
mxa
simultan
potenti
differenti
viral
infect
bacteri
diseas
elev
crp
viral
infect
would
also
associ
elev
mxa
wherea
mxa
level
would
normal
bacteri
infect
pct
peptid
precursor
calcitonin
hormon
synthes
parafollicular
c
cell
thyroid
regul
calcium
homeostasi
standard
refer
valu
pct
adult
children
older
hour
usual
ngml
less
respons
inflamm
associ
bacteri
endotoxin
inflammatori
cytokin
pct
elev
within
hour
peak
hour
halflif
hour
higher
procalcitonin
level
patient
bacteri
sepsi
associ
greater
likelihood
sever
sepsi
septic
shock
decreas
surviv
colon
carrier
state
without
system
host
respons
significantli
rais
procalcitonin
level
procalcitonin
level
fall
success
treatment
either
sever
bacteri
infect
noninfecti
inflammatori
stimuli
uri
tend
caus
modest
elev
pct
use
lower
pct
threshold
ngml
associ
polymeras
chain
bacteri
cultur
common
oral
pathogen
gabh
atyp
pathogen
chlamydophila
mycoplasma
would
suggest
true
activ
bacteri
infect
higher
pct
cutoff
ngml
could
use
associ
growth
typic
bacteri
colon
associ
neg
bacteri
cultur
suggest
activ
bacteri
infect
patient
without
anoth
confirm
sourc
infect
viral
infect
pct
respons
viral
infect
noninfecti
inflammatori
stimuli
autoimmun
diseas
chronic
inflammatori
process
typic
exceed
ngml
branch
et
al
found
viral
infect
pct
ngml
low
concentr
ngml
pct
inadequ
differenti
viral
bacteri
etiolog
crp
pct
level
correl
consist
primari
care
patient
uri
moder
predict
valu
clinic
outcom
crp
pct
shown
elev
infecti
pharyng
howev
crp
sensit
pct
specif
detect
bacteri
tonsillopharyng
acut
respiratori
infect
includ
uri
antibiot
therapi
base
either
biomark
alon
led
reduc
antibiot
prescript
without
increas
morbid
numer
studi
delin
util
crp
antibiot
stewardship
specif
decreas
antibiot
prescript
patient
respiratori
tract
infect
europ
crp
mgl
recommend
pneumonia
guidelin
nation
institut
health
care
excel
nice
trigger
prescrib
antibiot
use
crp
threshold
statist
signific
increas
patient
consult
emerg
visit
advers
outcom
recent
systemat
review
metaanalysi
studi
primari
care
includ
patient
crp
test
led
significantli
reduc
antibiot
prescrib
index
consult
without
increas
morbid
effect
crp
test
outcom
patient
gener
practic
evalu
recent
random
clinic
trial
total
patient
includ
crp
measur
group
control
group
result
suggest
crp
test
patient
acut
cough
may
reduc
antibiot
prescrib
referr
radiographi
without
compromis
outcom
similar
result
demonstr
identifi
patient
chronic
obstruct
pulmonari
diseas
copd
exacerb
need
antibiot
treatment
clinic
trial
use
pct
guid
antibiot
therapi
patient
acut
respiratori
tract
infect
shown
biomarkerdriven
algorithm
decreas
antibiot
prescrib
significantli
without
increas
advers
event
treatment
failur
pctguid
antibiot
stewardship
reduc
initi
antibiot
prescript
rate
patient
lower
respiratori
infect
lri
present
emerg
depart
ambulatori
patient
present
gener
physician
reduc
total
antibiot
exposur
communityacquir
pneumonia
singlecent
random
control
studi
signific
reduct
antibiot
use
patient
hospit
sever
acut
exacerb
asthma
shown
util
algorithm
pct
measur
studi
withhold
antibiot
treatment
caus
appar
harm
sever
clinic
studi
verifi
high
mxa
protein
level
strongli
correl
system
viral
infect
elev
crp
level
close
associ
bacteri
diseas
simultan
perform
crp
mxa
predict
increas
sensit
specif
identifi
bacteri
diseas
combin
mxa
detect
marker
specif
bacteri
infect
crp
could
greater
predict
valu
allow
reliabl
differenti
viral
bacteri
infect
use
marker
bacteri
infect
alon
high
mxa
without
elev
crp
would
strongli
suggest
viral
infecti
process
absenc
bacteri
infect
unlik
common
occurr
incident
identif
multipl
pathogen
op
np
true
activ
coinfect
lead
system
viral
bacteri
immun
respons
common
uri
viral
bacteri
pathogen
identifi
associ
pct
ngml
crp
mgl
may
support
diagnosi
true
coinfect
result
other
suggest
defin
ratio
crpmxa
would
optim
differenti
viral
bacteri
infect
rapid
crp
test
shown
promot
prudent
use
antibiot
primari
care
led
reduct
antibiot
prescript
prospect
multicent
crosssect
studi
adult
children
febril
uri
evalu
diagnost
accuraci
singleus
dispos
immunoassay
includ
crp
mxa
febridx
rp
diagnost
sarasota
fl
multicent
usbas
studi
enrol
patient
symptomat
patient
uri
asymptomat
patient
clinic
site
includ
academ
emerg
depart
commun
care
center
demonstr
neg
predict
valu
npv
bacteri
infect
also
use
crp
independ
mxa
would
led
overtreat
viral
infect
pattern
result
test
system
crp
pct
combin
mxa
may
assist
health
care
profession
identifi
immun
respons
suspect
viral
andor
bacteri
infect
greatli
enhanc
antibiot
stewardship
outpati
set
recent
demonstr
febridx
studi
children
adult
mean
age
year
evalu
use
mxa
plu
crp
guid
outpati
antibiot
manag
therapi
alter
unnecessari
antibiot
prescript
reduc
without
advers
effect
valu
inpati
antibiot
stewardship
embrac
mani
profession
societi
idsa
center
diseas
control
prevent
cdc
present
sever
recommend
guidelin
requir
licens
organ
continu
updat
diagnost
evolv
outcom
measur
improv
current
focu
inpati
fit
well
exist
hospit
surveil
program
abil
identifi
multipli
drugresist
organ
inpati
stewardship
driven
part
modern
microbiolog
often
avail
impract
outpati
set
outpati
stewardship
also
critic
difficult
implement
accord
cdc
american
colleg
physician
antibiot
cours
prescrib
outpati
set
inappropri
complet
unnecessari
equat
billion
direct
cost
addit
billion
indirect
cost
includ
antibioticresist
ill
antibiot
advers
event
secondari
infect
clostridium
difficil
diarrhea
major
obstacl
effect
outpati
antibiot
stewardship
appropri
antibiot
prescrib
difficulti
accur
defin
microbi
caus
respiratori
infect
especi
distinguish
viral
bacteri
etiolog
diagnosi
even
challeng
rapid
test
identifi
bacteri
pathogen
present
carrier
state
addit
attempt
differenti
bacteri
viral
infect
use
histori
physic
find
inaccur
onehalf
time
patient
may
also
symptom
mimick
infecti
process
actual
caus
hypersensit
especi
rhinoviru
coronaviru
act
directli
allergen
elicit
ige
elev
respons
may
lead
lowgrad
fever
exacerb
reactiv
airway
diseas
predispos
patient
histori
underli
allergi
atopi
asthma
copd
lastli
patient
expect
therapi
present
anoth
challeng
overcom
outpati
set
studi
parent
previsit
expect
receiv
antibiot
patient
expect
demand
antibiot
like
receiv
even
though
patient
satisfact
may
affect
prescrib
antibiot
one
approach
improv
appropri
outpati
antibiot
use
supplement
histori
physic
examin
pointofcar
test
select
biomark
biomark
crp
pct
mxa
respond
differ
host
immun
respons
help
distinguish
viral
bacteri
infect
includ
noninfecti
caus
symptom
low
level
crp
pct
sensit
specif
bacteri
infect
high
level
crp
pct
becom
specif
bacteri
infect
although
pct
crp
specif
enough
differenti
viral
bacteri
infect
biomark
combin
mxa
substanti
improv
differenti
diagnost
accuraci
combin
interpret
mxa
either
crp
pct
dramat
improv
sensit
specif
differenti
viral
bacteri
infect
rapid
pointofcar
test
measur
crp
mxa
avail
europ
canada
current
unit
state
util
result
febridx
test
outpati
clinic
practic
impress
encourag
includ
diagnost
accuraci
posit
impact
appropri
antibiot
prescrib
npv
reduc
clinician
fear
miss
seriou
bacteri
infect
support
watch
wait
abil
demonstr
tangibl
result
offic
visit
reliev
patient
pressur
antibiot
prescript
recent
survey
estim
us
primari
care
clinician
current
use
rapid
strep
test
use
rapid
flu
test
oftentim
patient
rapid
pointofcar
test
util
detect
mxa
crp
without
requir
ancillari
reader
equip
would
like
reduc
need
rapid
strep
flu
test
provid
direct
cost
save
reduc
indirect
cost
relat
cost
unnecessari
antibiot
advers
event
potenti
resist
summari
critic
import
antibiot
stewardship
rapidli
move
outpati
set
diagnost
algorithm
base
sole
histori
physic
histor
inaccur
mani
common
outpati
syndrom
incorpor
pointofcar
test
combin
biomark
crp
mxa
extrem
use
import
adjunct
tradit
method
studi
direct
toward
delin
biomark
util
outpati
set
